Key facts for J9017
- Billing unit
- 1 MG
- Arsenic trioxide injection
- ASP payment limit
- $3.837
- October 2026; -24.3% vs July 2026
- Practitioner MUE
- 30
- MAI 3
- OPPS status
- SI N
- NCCI exposure
- no PTP pairs
- Coverage articles
- 0
- none list this code
TL;DR
HCPCS J9017 is the Level II code for Injection, arsenic trioxide, 1 mg, billed per 1 MG. The Medicare Part B ASP payment limit for October 2026 is $3.837 per billing unit, down 24.3% from July 2026. The practitioner MUE allows up to 30 units per date of service (MAI 3), so a full 30-unit day is $115.11 at the current limit. Under OPPS it carries status indicator N. With a 1 mg billing unit, a single administration can be hundreds of units; the unit count on the claim must equal the milligrams given, and rounding rules for partial units follow the contractor's guidance. The ASP crosswalk maps 22 NDCs to it, sold as Arsenic Trioxide, Trisenox by Sandoz Inc., Nexus Pharmaceuticals, LLC, Heritage Pharmaceuticals Inc. No current Billing and Coding Article lists J9017, so coverage follows the FDA label, compendia and any applicable NCD.
Medicare Part B payment limit (ASP)
CMS sets the Part B payment limit for J9017 at $3.837 per 1 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $5.069 in July 2026. Beneficiary coinsurance is 20%.
| Quarter | Payment limit | Per | Coinsurance |
|---|---|---|---|
| October 2026 | $3.837 | 1 MG | 20% |
| July 2026 | $5.069 | 1 MG | — |
NDC to HCPCS billing-unit conversion
The October 2026 ASP crosswalk maps 22 NDCs from 13 labelers to J9017. Report the NDC in the claim's drug segment and bill the number of J9017 units that equals the quantity administered divided by 1 MG; the last column gives units per full package.
| NDC | Drug name | Labeler | Package size | Billing units / package |
|---|---|---|---|---|
| 00781-3498-94 | Arsenic Trioxide | Sandoz Inc. | 6 × 1 | 12 |
| 00781-3498-95 | Arsenic Trioxide | Sandoz Inc. | 6 × 10 | 120 |
| 14789-0600-10 | Arsenic Trioxide | Nexus Pharmaceuticals, LLC | 10 × 10 | 100 |
| 23155-0869-41 | Arsenic Trioxide | Heritage Pharmaceuticals Inc. | 10 × 10 | 100 |
| 23155-0870-41 | Arsenic Trioxide | Heritage Pharmaceuticals Inc. | 6 × 10 | 120 |
| 25021-0226-10 | Arsenic Trioxide | Sagent Pharmaceuticals | 10 × 10 | 100 |
| 25021-0227-06 | Arsenic Trioxide | Sagent Pharmaceuticals | 6 × 10 | 120 |
| 50742-0438-10 | Arsenic Trioxide | Ingenus Pharmaceuticals LLC | 10 × 1 | 10 |
| 63323-0637-10 | Arsenic Trioxide | FreseniUS Kabi USA, LLC | 10 × 10 | 100 |
| 63459-0601-06 | Trisenox | Cephalon, LLC | 6 × 10 | 120 |
| 68382-0997-10 | Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 10 × 10 | 100 |
| 69918-0720-02 | Arsenic Trioxide | Nordic Pharma, Inc | 10 × 2 | 20 |
| 69918-0720-10 | Arsenic Trioxide | Nordic Pharma, Inc | 10 × 10 | 100 |
| 70121-1483-07 | Arsenic Trioxide | Amneal Pharmaceuticals, LLC | 10 × 10 | 100 |
| 70121-1658-01 | Arsenic Trioxide | Amneal Pharmaceuticals, LLC | 6 × 10 | 120 |
| 70710-1610-06 | Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 6 × 10 | 120 |
| 70710-1895-06 | Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 10 × 10 | 100 |
| 70710-1896-06 | Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 6 × 10 | 120 |
| 70860-0217-10 | Arsenic Trioxide | Athenex Pharmaceutical Division, LLC | 10 × 1 | 10 |
| 72205-0171-07 | Arsenic Trioxide | Novadoz Pharmaceuticals LLC | 10 × 10 | 100 |
| 72205-0172-07 | Arsenic Trioxide | Novadoz Pharmaceuticals LLC | 6 × 10 | 120 |
| 72603-0339-10 | Arsenic Trioxide | Northstar RxLLC | 10 × 10 | 100 |
Medically Unlikely Edits (MUE)
CMS publishes 3 MUE values for J9017. For practitioners the limit is 30 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.
| Setting | MUE (units/DOS) | MAI | CMS rationale |
|---|---|---|---|
| Practitioner services | 30 | 3 Date of Service Edit: Clinical | Clinical: Data |
| Facility outpatient hospital | 30 | 3 Date of Service Edit: Clinical | Clinical: Data |
| DME supplier | 0 | 3 Date of Service Edit: Clinical | CMS Policy |
MUE for J9017 in every setting opens the lookup with this code filled in, next to any other code on the same claim.
NCCI edits and add-on relationships
No active practitioner PTP pair lists J9017 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.
The counts above are exposure, not answers for a specific claim. Check J9017 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.
J9017 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.
Medicare coverage articles
No current Billing and Coding Article lists J9017 in its HCPCS table. Coverage then follows the drug's FDA label, compendia and any National Coverage Determination; check the Medicare Coverage Database before administering off-label.
Hospital outpatient (OPPS) status
In the October 2026 OPPS Addendum B, J9017 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.
Ambulatory surgical center (ASC) payment
In the October 2026 ASC Addendum BB (covered ancillary services), J9017 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.
Common denials for J9017 and how to prevent them
For teams evaluating QuickIntell software
Evaluate a coding workflow for J9017
Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
In QuickIntell research
- October 2026 ASP movers report: J9017's payment limit moved -24.3% against July 2026, one of 75 drug codes that moved 20% or more.
- J codes by drug name: Every code for the same drug, generic or brand, in one A-Z index.
Frequently asked questions — HCPCS J9017
What does HCPCS code J9017 describe?
J9017 is defined by CMS as "Injection, arsenic trioxide, 1 mg". Each billing unit represents 1 MG, so the units reported on the claim must equal the dose administered divided by that unit.
Is J9017 a CPT code?
No. J9017 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as arsenic trioxide (Trisenox); CPT codes are five-character codes maintained by the AMA. On a Part B claim J9017 reports the drug itself in 1 mg units, and the administration is billed on its own line.
What is the Medicare reimbursement for J9017 in October 2026?
The ASP-based payment limit is $3.837 per 1 MG, with 20% beneficiary coinsurance. The July 2026 limit was $5.069. Commercial payers use their own fee schedules.
How many units of J9017 can be billed per day?
The practitioner Medically Unlikely Edit is 30 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Clinical: Data" as the rationale.
Which NDCs map to J9017?
The October 2026 ASP crosswalk lists 22 NDCs from 13 labelers: Arsenic Trioxide (Sandoz Inc.); Arsenic Trioxide (Nexus Pharmaceuticals, LLC); Arsenic Trioxide (Heritage Pharmaceuticals Inc.); Arsenic Trioxide (Sagent Pharmaceuticals). For example NDC 00781-3498-94 (package size 6) equals 12 billing units of J9017.
Does J9017 have NCCI bundling edits?
No active practitioner PTP pairs list J9017 as a column-1 or column-2 code in the v323r0 release.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- HCPCS Level II alpha-numeric file, October 2026Version October 2026 · effective 2026-10-01 · file HCPC2026_OCT_ANWEB_09232026.txtSHA-256 c25240c63108756d…
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- Medicare Part B Drug Payment Limit File, July 2026Version July 2026 · effective 2026-07-01 · file section 508 version of July 2026 Medicare Part B Payment Limit File updated 082026.csvSHA-256 13bb5b644b92b574…
- ASP NDC-HCPCS Crosswalk, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 ASP NDC-HCPCS Crosswalk 091126.csvSHA-256 5cb78f0c2ee786ba…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI MUE table, facility services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_OutpatientHospitalServices_Eff_10-01-2026.csvSHA-256 3af9f4e99cc587e2…
- NCCI MUE table, dme services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_DMESupplierServices_Eff_10-01-2026.csvSHA-256 6fa4fbba852f7b74…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- NCCI Add-On Code edits, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file AOC_V2026Q4-F-MCR.xlsxSHA-256 eabb519623134549…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
- ASC Addendum BB (covered ancillary services), October 2026Version October 2026 · effective 2026-10-01 · file Oct 2026 ASC BB.txtSHA-256 63cdd7c72aba7a25…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
Disclaimer
This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.